ShareValue scores for 600222.SHG: Valuation 47, Quality 37, Growth 49, Health 32.

600222.SHG
SSE

Henan Taloph Pharmaceutical Stock Co Ltd

CN¥7.82(+2.49%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

2% to 17%
Valuation
47
Fair Value
Price vs Value
Quality
37
Weak
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
32
Stressed
Financial Stability
Momentum
37
Bearish
Price Trend

Company Details

About

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the manufacture and sale of pharmaceutical preparations and Chinese herbal medicine slices in China. The company offers Shuanghuanglian oral liquid series, Shuangjinlian mixture, children's heat-clearing and cough-relieving oral liquid series, pediatric antipyretic oral liquid, Jiaweishanxiang Zhengqi compound preparation, honeysuckle dew, danshen oral liquid, Shengmai Yin, pediatric compound chicken gizzard chewable tablets, Chewable tablets, huperzine A tablets, Wuzi Yanzong oral liquid, compound motherwort oral liquid, etc. It is also involved in pharmaceutical research and development, and medicine and medicinal materials distribution. The company's medicine preparations are used in the treatment of respiratory system, cardiovascular and cerebrovascular, digestive system, nervous system, menstrual system, reproductive system, and gynecological diseases. Henan Taloph Pharmaceutical Stock Co.,Ltd was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. The company was founded in 1998 and is based in Zhengzhou, China. Address: No. 8 Jinsuo Road, Zhengzhou, China, 450001

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026